Harmony Biosciences Holdings Inc — Liquidità (NASDAQ:HRMY) | MetaTrader

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche

Trimestrale Annuale

Flusso di cassa derivante dalle attività operative -2.98 M98.56 M144.47 M219.39 M219.82 M348.2 M 348.2 M Flussi di cassa derivanti dalle attività di investimento -2 M-100.3 M-141.83 M-46.44 M-67.48 M-39.65 M -39.65 M Liquidità derivante dalle attività di finanziamento 209.16 M7.42 M6.84 M-105.55 M-11 M-9.05 M -9.05 M Liquidità libera -2.99 M98.26 M144.29 M219.07 M218.67 M347.89 M 347.89 M

Notizie

Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript

BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y

IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress

RXRX Q4 Loss Narrower Than Expected, Revenues Increase Y/Y, Stock Up

Corcept's Q4 Earnings and Revenues Fall Short of Estimates

Repligen's Q4 Earnings Beat Estimates, Revenues Surge Y/Y

Apellis Q4 Loss Wider Than Expected, Revenues Decline Y/Y

UBS taglia il target su Harmony Biosciences per ingresso anticipato dei generici di Wakix

UBS cuts Harmony Biosciences stock price target on earlier Wakix generic entry

Truist conferma Hold su Harmony Biosciences, target a $25

Truist reiterates Hold on Harmony Biosciences stock, sets $25 target

AXSM Q4 Loss Wider Than Expected, Revenues Surge Y/Y on Auvelity Sales